Related Experiment Video

Updated: Aug 9, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis

Tomoyuki Inoue1, David L Boyle, Maripat Corr

  • 1Division of Rheumatology, Allergy, and Immunology, University of California at San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093-0656, USA.

Proceedings of the National Academy of Sciences of the United States of America
|March 29, 2006
PubMed

Insights

Targeting MAPK kinase 3 (MKK3) in mice significantly reduced inflammatory arthritis and associated cytokine production. This selective MKK3 deficiency suppressed inflammatory responses while preserving host defense mechanisms.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • p38 mitogen-activated protein kinase (MAPK) is crucial for regulating cytokines involved in arthritis.
  • MAPK kinase (MKK) 3 and MKK6 regulate p38 MAPK activity.
  • Targeting MKK3 offers a potential strategy to modulate p38 function with reduced toxicity.

Purpose of the Study:

  • To evaluate the therapeutic potential of targeting MKK3 in inflammatory arthritis.
  • To investigate the role of MKK3 in p38 MAPK activation and cytokine production in vitro and in vivo.
  • To determine if MKK3 deficiency impacts host defense mechanisms.

Main Methods:

  • Utilized MKK3 knockout (MKK3(-/-)) mice and wild-type (WT) littermates.
  • Stimulated cultured synoviocytes with TNF-alpha, IL-1beta, or LPS.
  • Assessed p38 MAPK phosphorylation, cytokine levels (IL-1beta, IL-6), NF-kappaB activation, and inflammatory markers in two arthritis models.

Main Results:

  • MKK3(-/-) synoviocytes showed reduced p38 activation and lower IL-1beta and IL-6 expression upon TNF-alpha stimulation.
  • TNF-alpha-induced NF-kappaB activation was MKK3-dependent, unlike LPS-mediated activation.
  • MKK3(-/-) mice exhibited significantly reduced arthritis severity and lower levels of inflammatory mediators in joints.
  • IL-1beta administration could restore arthritis severity in MKK3(-/-) mice.
  • IL-6 production following systemic LPS administration was comparable between MKK3(-/-) and WT mice.

Conclusions:

  • Selective MKK3 deficiency effectively suppresses inflammatory arthritis and associated cytokine production.
  • MKK3 plays a critical role in TNF-alpha-driven inflammatory pathways relevant to arthritis.
  • Targeting MKK3 preserves Toll-like receptor 4-mediated host defense, suggesting a potential therapeutic window.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...